Topics


Gliomas | Treatment | Targeted therapy






Home > Publications > Topics > Gliomas > Treatment > Targeted therapy






OVERVIEW






64Cu-ATSM










BEVACIZUMAB










DABRAFENIB










EGFR INHIBITORS

ERDAFITINIB









IDH INHIBITORS

INFIGRATINIB

IVOSIDENIB








LAROTRECTINIB










NIVOLUMAB










PEPTIDE-BASED THERAPY










RADIONUCLIDE THERAPY

BRAF/MEK INHIBITORS









PARP INHIBITORS

PRITUMUMAB









SAFUSIDENIB

STEM CELL THERAPY









TOVORAFENIB

TRAMETINIB









ULIXERTINIB










VORASIDENIB